Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
CDSCO committee recommends Wockhardt’s novel antibiotic Miqnaf for CABP treatment
The recommendation clears the path for final approval from the DCGI following extensive clinical studies
Aerogen and Indian Association of Respiratory Care sign MoU to advance respiratory therapy education…
Collaboration aims to enhance training, improve patient outcomes, and raise awareness of aerosol drug delivery across India
MILOS study highlights potential of bempedoic acid to advance dyslipidemia treatment: GlobalData
MILOS study underscores the potential of bempedoic acid to enhance dyslipidemia treatment, particularly for patients with statin…
Jubilant Biosys signs partnership with Pierre Fabre SA
The partnership will add to Jubilant Biosys' drug discovery and preclinical development capabilities in biologics and antibody…
Alkem signs agreement with US-based Sonnet BioTherapeutics to develop, commercialise its drug…
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India to enable global and India…
Zydus gains final USFDA approval for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and…
The tablets are indicated for the acute and maintenance treatment of schizophrenia
Nutrabay launches ayurvedic supplement Shilajit
Shilajit will be available on the brand’s D2C website, popular online marketplaces like Amazon and Flipkart, and in retail stores…
The next industrial revolution in India will be driven by biotechnology
Dr Jitendra Singh noted that the number of biotech startups has risen from just 50 in 2014 to over 5,000 now, reflecting India’s…
BizDateUp leads USD 1 million pre-IPO round in pharma packaging startup Sorich
Funds will enhance Sorich's production capacity, strengthen working capital, and advance patented products
Biocon Biologics report explores pathways to increase biosimilar adoption in low- and middle-income…
Biocon Biologics' study identifies six policy recommendations to improve access to biosimilars in LMICs, addressing healthcare…